These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry). Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH; Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051 [TBL] [Abstract][Full Text] [Related]
9. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis. Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735 [TBL] [Abstract][Full Text] [Related]
10. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents. Iijima R; Mehilli J; Schömig A; Kastrati A Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392 [TBL] [Abstract][Full Text] [Related]
11. Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagus. Machan L Adv Drug Deliv Rev; 2006 Jun; 58(3):447-62. PubMed ID: 16713011 [TBL] [Abstract][Full Text] [Related]
12. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent. Beijk MA; Piek JJ Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467 [TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent. Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204 [TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents. Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841 [TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638 [TBL] [Abstract][Full Text] [Related]
16. All drug-eluting stents are equal, but some drug-eluting stents are more equal than others. Strauss BH J Am Coll Cardiol; 2006 Oct; 48(7):1310-1. PubMed ID: 17010787 [No Abstract] [Full Text] [Related]
17. Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent. Visconti G; Taranto D; Briguori C Catheter Cardiovasc Interv; 2008 Nov; 72(6):873-6. PubMed ID: 19009632 [TBL] [Abstract][Full Text] [Related]
18. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice]. Er F; Erdmann E Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349 [TBL] [Abstract][Full Text] [Related]
19. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753 [TBL] [Abstract][Full Text] [Related]
20. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Nordmann AJ; Briel M; Bucher HC Eur Heart J; 2006 Dec; 27(23):2784-814. PubMed ID: 17020889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]